Skip to Main Content

Author Details

Pinaki Bose
Cumming School of Medicine, University of Calgary
2008
45
19
PMIDPaper TitleJournal TitlePublished Year
36635327NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.Cancer Gene Ther2023
37596273Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response.Nat Commun2023
37515162Modulation of Reoviral Cytolysis (II): Cellular Stemness.Viruses2023
37532697Development and validation of a 21-gene prognostic signature in neuroblastoma.Sci Rep2023
37067922Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor-Initiating Cells.Cancer Res2023
36841881PDGF gene expression and p53 alterations contribute to the biology of diffuse astrocytic gliomas.NPJ Genom Med2023
36497424Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers.Cancers (Basel)2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
34242269The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.PLoS One2021
33560410In the beginning: PDGFA and the genesis of GBM.Neuro Oncol2021
33694259Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.Brain Pathol2021
34739319PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway.Sci Adv2021
32238578Control of brain tumor growth by reactivating myeloid cells with niacin.Sci Transl Med2020
31713485In Vitro Investigation Demonstrates IGFR/VEGFR Receptor Cross Talk and Potential of Combined Inhibition in Pediatric Central Nervous System Atypical Teratoid Rhabdoid Tumors.Curr Cancer Drug Targets2020
33291370TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts.Cancers (Basel)2020
33020472Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.Nat Commun2020
32153581Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes.Front Immunol2020
32183301ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.Cancers (Basel)2020
32303715Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.Br J Cancer2020
31481733Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.Br J Cancer2019
31471491Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.Proc Natl Acad Sci U S A2019
30327548Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.Sci Rep2018
30288344Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity.Oncoimmunology2018
30410077TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure.Nat Commun2018
28782304Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population-based study.Head Neck2017
29098033Impact of tumoral carbonic anhydrase IX and Ki-67 expression on survival in oral squamous cell carcinoma patients.Oncol Lett2017
29246904Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.Clin Cancer Res2017
25258367MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma.AJNR Am J Neuroradiol2015
26095605Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes.Stem Cell Reports2015
26173781Integrative genomic analysis of ghost cell odontogenic carcinoma.Oral Oncol2015
25976920Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.BMC Cancer2015
24912621Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients.Oncotarget2014
23417723Head and neck cancer: from anatomy to biology.Int J Cancer2013
23907133Identifying the stromal cell type that contributes to tumor aggressiveness associated with carbonic anhydrase IX.Cell Cycle2013
24008732ING1 induces apoptosis through direct effects at the mitochondria.Cell Death Dis2013
24008660The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.Br J Cancer2013
22359620Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma.PLoS One2012
22892062Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.Eur J Cancer2012
22852863Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.BMC Cancer2012
22366443High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.Oral Oncol2012
22206574Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition.Cancer Cell Int2011
20681406The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.Oncol Res2010
21067583REAP: A two minute cell fractionation method.BMC Res Notes2010
18801192Interspecies data mining to predict novel ING-protein interactions in human.BMC Genomics2008
18836436Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.Nat Cell Biol2008
  • 1 - 45 of 45

Recommended Authors

Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 1
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Tathiane M Malta
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo
Career Start Year 2008
Number of shared co-authors 0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 3
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 4
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 1
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Roel G W Verhaak
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 4
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 1
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 5
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
Robert Cornelison
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 3
Rifat Hasina
University of Chicago Medicine
Career Start Year 1999
Number of shared co-authors 0
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 8
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Mitchell J Frederick
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 5
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 2

Collaborators

Joseph C Dort
Cumming School of Medicine, University of Calgary
Co-authored papers 15
Steven J M Jones
University of British Columbia
Co-authored papers 6
Marco A Marra
University of British Columbia
Co-authored papers 5
Elizabeth N Kornaga
Tom Baker Cancer Centre
Co-authored papers 4
Yussanne Ma
Co-authored papers 3
Andrew J Mungall
Co-authored papers 3
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers 3
Richard A Moore
Co-authored papers 3
Susan P Lees-Miller
University of Calgary, 0 Hospital Drive NW
Co-authored papers 3
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 2
Janessa Laskin
Co-authored papers 2
Carolyn Ch'ng
GenomeDx Biosciences Inc.
Co-authored papers 2
Cameron J Grisdale
Biodiversity Research Centre and Department of Botany, University of British Columbia
Co-authored papers 2
Martin R Jones
BC Cancer Research Centre.
Co-authored papers 2
Caralyn Reisle
University of British Columbia
Co-authored papers 2
Alice Dawson
University of Dundee
Co-authored papers 1
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 1
Dolores Hambardzumyan
Co-authored papers 1
Francisco Laxague
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 1
Cheryl Ho
University of British Columbia
Co-authored papers 1
Eitan Prisman
University of British Columbia
Co-authored papers 1
Catherine F Poh
University of British Columbia
Co-authored papers 1
Sarah E B Ryan
University of Western Ontario
Co-authored papers 1
Mushfiq H Shaikh
University of Western Ontario
Co-authored papers 1
Ian Bosdet
University of British Columbia
Co-authored papers 1
Christopher J Howlett
Western University
Co-authored papers 1
Jake Lever
University of Glasgow
Co-authored papers 1
Karlyne M Reilly
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Mara S Serafini
Fondazione IRCCS Istituto Nazionale dei Tumouri
Co-authored papers 1
Kathrin Scheckenbach
Heinrich-Heine University
Co-authored papers 1
Release 1.2